FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories Venlafaxine Hydrochloride Recall

Venlafaxine Hydrochloride, extended-release capsules, USP, 37

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories · La Vergne, TN

Risk level
Class II
Reported by FDA
Jul 10, 2024
Recall ID
D-0584-2024
Check your lot numberHow we source this data

Summary

The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalled Venlafaxine Hydrochloride starting Jun 18, 2024. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0584-2024 on Jul 10, 2024. Reason: Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution. Status: Terminated.

Why it was recalled

Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.

Product description

Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614

Lot numbers, UPCs & expiration codes

Lot code: M04614, Exp 09/30/2024

Where it was sold

Nationwide. No foreign consignees.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0584-2024
Classification
Class II
Status
Terminated
Recall initiated
Jun 18, 2024
FDA report date
Jul 10, 2024
Quantity
864 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Original FDA data

Every field from FDA enforcement report D-0584-2024, exactly as published.

Show all FDA fields
City
La Vergne
State
TN
Status
Terminated
Country
United States
Event ID
94835
Address
341 Mason Rd
Code information
Lot code: M04614, Exp 09/30/2024
Postal code
37086-3606
Report date
Jul 10, 2024
Product type
Drugs
Recall number
D-0584-2024
Classification
Class II
Recalling firm
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Product quantity
864 cartons
Termination date
Dec 22, 2025
Reason for recall
Failed dissolution specifications: out of specification result obtained during routine stability testing for high dissolution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Venlafaxine Hydrochloride, extended-release capsules, USP, 37.5mg, 10 x 10 blister card in one carton, Rx only, Mfg by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by: Major Pharmaceutical 17177 N Laurel Park Dr., Suite 233, Livonia, MI 48152, USA, NDC 0904-7075-61, UPC code: 309047075614
Distribution pattern
Nationwide. No foreign consignees.
Recall initiation date
Jun 18, 2024
Initial firm notification
Letter
Center classification date
Jul 3, 2024

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0584-2024, published Jul 10, 2024. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls